Sarah Kathryn Rouan
CIK 1761366 · last filed 2026-01-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$126.2K
Companies
3
Total Filings
19
Lifetime Open-Market Net
-$2.22M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VKTX | Director | 4,390 | $28.75 | $126.2K | -$2.22M | 10 | 2026-01-05 |
| NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Director | 18,242 | $0.00 | $2 | $4.9K | 6 | 2021-07-07 |
| Viking Therapeutics, Inc. (VKTXW) Delisted | Director | — | $4.60 | — | $0 | 3 | 2021-01-06 |
Recent Filings · Page 2 of 2
19 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-07-07 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | +4,892 | $0 | EDGAR |
| 2021-01-14 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | +2,500 | $2 | EDGAR |
| 2021-01-06 | Viking Therapeutics, Inc. (VKTXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-07 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | +2,500 | $2 | EDGAR |
| 2020-01-03 | Viking Therapeutics, Inc. (VKTXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-07-02 | Viking Therapeutics, Inc. (VKTXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-21 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Buy (P) | +3,350 | $4.9K | EDGAR |
| 2019-02-12 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | +50,000 | $50 | EDGAR |
| 2019-01-03 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | +50,000 | $50 | EDGAR |
Showing 11–19 of 19
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.